136 related articles for article (PubMed ID: 16740140)
21. Tumor necrosis factor-α induced protein 8 polymorphism and risk of non-Hodgkin's lymphoma in a Chinese population: a case-control study.
Zhang Y; Wang MY; He J; Wang JC; Yang YJ; Jin L; Chen ZY; Ma XJ; Sun MH; Xia KQ; Hong XN; Wei QY; Zhou XY
PLoS One; 2012; 7(5):e37846. PubMed ID: 22666399
[TBL] [Abstract][Full Text] [Related]
22. Gene polymorphisms in Toll-like receptors, interleukin-10, and interleukin-10 receptor alpha and lymphoma risk.
Nieters A; Beckmann L; Deeg E; Becker N
Genes Immun; 2006 Dec; 7(8):615-24. PubMed ID: 16971956
[TBL] [Abstract][Full Text] [Related]
23. NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population.
Angeletti S; Galluzzo S; Santini D; Ruzzo A; Vincenzi B; Ferraro E; Spoto C; Lorino G; Graziano N; Calvieri A; Magnani M; Graziano F; Pantano F; Tonini G; Dicuonzo G
Hum Immunol; 2009 Sep; 70(9):729-32. PubMed ID: 19397946
[TBL] [Abstract][Full Text] [Related]
24. SHMT1 C1420T polymorphism contributes to the risk of non-Hodgkin lymphoma: evidence from 7309 patients.
Wang YW; Zhang SD; Xue WJ; Zhu ML; Zheng LZ
Chin J Cancer; 2015 Dec; 34(12):573-82. PubMed ID: 26666829
[TBL] [Abstract][Full Text] [Related]
25. Association between folate-metabolizing pathway polymorphism and non-Hodgkin lymphoma.
Kim HN; Lee IK; Kim YK; Tran HT; Yang DH; Lee JJ; Shin MH; Park KS; Shin MG; Choi JS; Kim HJ
Br J Haematol; 2008 Feb; 140(3):287-94. PubMed ID: 18042267
[TBL] [Abstract][Full Text] [Related]
26. Polymorphisms in cytochrome P450 17A1 and risk of non-Hodgkin lymphoma.
Skibola CF; Lightfoot T; Agana L; Smith A; Rollinson S; Kao A; Adamson P; Morgan GJ; Smith MT; Roman E
Br J Haematol; 2005 Jun; 129(5):618-21. PubMed ID: 15916684
[TBL] [Abstract][Full Text] [Related]
27. A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphoma.
Purdue MP; Lan Q; Wang SS; Kricker A; Menashe I; Zheng TZ; Hartge P; Grulich AE; Zhang Y; Morton LM; Vajdic CM; Holford TR; Severson RK; Leaderer BP; Cerhan JR; Yeager M; Cozen W; Jacobs K; Davis S; Rothman N; Chanock SJ; Chatterjee N; Armstrong BK
Carcinogenesis; 2009 Feb; 30(2):275-81. PubMed ID: 19029192
[TBL] [Abstract][Full Text] [Related]
28. Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL loci.
Wang SS; Vajdic CM; Linet MS; Slager SL; Voutsinas J; Nieters A; de Sanjose S; Cozen W; Alarcón GS; Martinez-Maza O; Brown EE; Bracci PM; Lightfoot T; Turner J; Hjalgrim H; Spinelli JJ; Zheng T; Morton LM; Birmann BM; Flowers CR; Paltiel O; Becker N; Holly EA; Kane E; Weisenburger D; Maynadie M; Cocco P; Foretova L; Staines A; Davis S; Severson R; Cerhan JR; Breen EC; Lan Q; Brooks-Wilson A; De Roos AJ; Smith MT; Roman E; Boffetta P; Kricker A; Zhang Y; Skibola C; Chanock SJ; Rothman N; Benavente Y; Hartge P; Smedby KE
Am J Epidemiol; 2015 Mar; 181(6):406-21. PubMed ID: 25713336
[TBL] [Abstract][Full Text] [Related]
29. Polymorphisms in the estrogen receptor 1 and vitamin C and matrix metalloproteinase gene families are associated with susceptibility to lymphoma.
Skibola CF; Bracci PM; Halperin E; Nieters A; Hubbard A; Paynter RA; Skibola DR; Agana L; Becker N; Tressler P; Forrest MS; Sankararaman S; Conde L; Holly EA; Smith MT
PLoS One; 2008 Jun; 3(7):e2816. PubMed ID: 18636124
[TBL] [Abstract][Full Text] [Related]
30. Organochlorine exposure, immune gene variation, and risk of non-Hodgkin lymphoma.
Colt JS; Rothman N; Severson RK; Hartge P; Cerhan JR; Chatterjee N; Cozen W; Morton LM; De Roos AJ; Davis S; Chanock S; Wang SS
Blood; 2009 Feb; 113(9):1899-905. PubMed ID: 19066394
[TBL] [Abstract][Full Text] [Related]
31. Combined polymorphisms in genes encoding the inflammasome components NALP3 and CARD8 confer susceptibility to Crohn's disease in Swedish men.
Schoultz I; Verma D; Halfvarsson J; Törkvist L; Fredrikson M; Sjöqvist U; Lördal M; Tysk C; Lerm M; Söderkvist P; Söderholm JD
Am J Gastroenterol; 2009 May; 104(5):1180-8. PubMed ID: 19319132
[TBL] [Abstract][Full Text] [Related]
32. The Effect of Caspase 8, 9 Gene Polymorphisms on Non-Hodgkin Lymphoma Susceptibility and Clinical/Pathological Features.
Barati F; Bahari G; Asadi A; Nakhaee A; Hashemi SM; Taheri M; Hashemi M
Asian Pac J Cancer Prev; 2022 Dec; 23(12):4339-4346. PubMed ID: 36580018
[TBL] [Abstract][Full Text] [Related]
33. Polymorphisms of genes involved in innate immunity: association with preterm delivery.
Härtel Ch; Finas D; Ahrens P; Kattner E; Schaible T; Müller D; Segerer H; Albrecht K; Möller J; Diedrich K; Göpel W;
Mol Hum Reprod; 2004 Dec; 10(12):911-5. PubMed ID: 15516360
[TBL] [Abstract][Full Text] [Related]
34. The +252A/G polymorphism in the Lymphotoxin-α gene and the risk of non-Hodgkin lymphoma: a meta-analysis.
Cao C; Liu S; Lou SF; Liu T
Eur Rev Med Pharmacol Sci; 2014; 18(4):544-52. PubMed ID: 24610621
[TBL] [Abstract][Full Text] [Related]
35. Genetic variation in H2AFX contributes to risk of non-Hodgkin lymphoma.
Novik KL; Spinelli JJ; Macarthur AC; Shumansky K; Sipahimalani P; Leach S; Lai A; Connors JM; Gascoyne RD; Gallagher RP; Brooks-Wilson AR
Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1098-106. PubMed ID: 17548670
[TBL] [Abstract][Full Text] [Related]
36. Association with TP53 codon 72 polymorphism and the risk of non-Hodgkin lymphoma.
Kim HN; Yu L; Kim NY; Lee IK; Kim YK; Yang DH; Lee JJ; Shin MH; Park KS; Choi JS; Kim HJ
Am J Hematol; 2010 Oct; 85(10):822-4. PubMed ID: 20734458
[TBL] [Abstract][Full Text] [Related]
37. Genetic polymorphisms in the one-carbon metabolism pathway genes and susceptibility to non-Hodgkin lymphoma.
Suthandiram S; Gan GG; Mohd Zain S; Bee PC; Lian LH; Chang KM; Ong TC; Mohamed Z
Tumour Biol; 2015 Mar; 36(3):1819-34. PubMed ID: 25384508
[TBL] [Abstract][Full Text] [Related]
38. [Association between cytotoxic T lymphocyte protein-4 polymorphisms and non-Hodgkin's lymphoma risk: a meta-analysis].
Yi B; Pei Y; Wang C; Jiang Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Aug; 32(8):1099-104. PubMed ID: 27412943
[TBL] [Abstract][Full Text] [Related]
39. Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma.
Cerhan JR; Ansell SM; Fredericksen ZS; Kay NE; Liebow M; Call TG; Dogan A; Cunningham JM; Wang AH; Liu-Mares W; Macon WR; Jelinek D; Witzig TE; Habermann TM; Slager SL
Blood; 2007 Dec; 110(13):4455-63. PubMed ID: 17827388
[TBL] [Abstract][Full Text] [Related]
40. Cyclin D1 splice variant and risk for non-Hodgkin lymphoma.
Wang SS; Cozen W; Severson RK; Hartge P; Cerhan JR; Davis S; Welch R; Rothman N; Chanock SJ
Hum Genet; 2006 Sep; 120(2):297-300. PubMed ID: 16783567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
